NeuPath Health Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

NeuPath Health şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Aug 18

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

Jun 16

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Apr 23

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Mar 01

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Dec 20

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Aug 19

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: NPTH şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: NPTH şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

NeuPath Health Piyasaya Karşı Temettü Getirisi

NPTH temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (NPTH)	n/a
Pazarın Alt %25'i (CA)	1.8%
Pazarın En İyi %25'i (CA)	6.2%
Sektör Ortalaması (Healthcare)	3.5%
Analist tahmini (NPTH) (3 yıla kadar)	n/a

Önemli Temettü: NPTH şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, NPTH şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: NPTH şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: NPTH herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

NeuPath Health Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Third quarter 2024 earnings released: CA$0.007 loss per share (vs CA$0.007 profit in 3Q 2023)

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Second quarter 2024 earnings released: EPS: CA$0.005 (vs CA$0.001 in 2Q 2023)

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

First quarter 2024 earnings released: CA$0.007 loss per share (vs CA$0.004 loss in 1Q 2023)

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

NeuPath Health Inc., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings released: CA$0.002 loss per share (vs CA$0.086 loss in FY 2022)

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Third quarter 2023 earnings released: EPS: CA$0.007 (vs CA$0.022 loss in 3Q 2022)

An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc. (TSXV:NPTH).

An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc. (TSXV:NPTH).

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Second quarter 2023 earnings released: EPS: CA$0.001 (vs CA$0.007 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.019 loss in 1Q 2022)

Full year 2022 earnings released: CA$0.086 loss per share (vs CA$0.072 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.022 loss per share (vs CA$0.014 loss in 3Q 2021)

High number of new and inexperienced directors

NeuPath Health Inc Announces Board Changes

NeuPath Health Inc. Announces Resignation of Dianne Carmichael as Director and Executive Chair

Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.025 loss in 2Q 2021)

NeuPath Health Inc. Announces Grant Connelly Step Down from Chief Executive Officer, on or Before August 19, 2022

First quarter 2022 earnings released: CA$0.019 loss per share (vs CA$0.016 loss in 1Q 2021)

High number of new and inexperienced directors

NeuPath Health Inc., Annual General Meeting, Jun 22, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Third quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.01 loss in 3Q 2020)

NeuPath Health Inc. (TSXV:NPTH) completed the acquisition of KumoCare Inc.

Second quarter 2021 earnings released

CFO & Corporate Secretary Stephen Lemieux has left the company

NeuPath Health Inc. (TSXV:NPTH) agreed to acquire KumoCare Inc. for $1.1 million.

First quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.05 loss in 1Q 2020)

NeuPath Health Inc. Announces Revenue Guidance for the First Quarter of 2021

Full year 2020 earnings released

NeuPath Health Inc. (TSXV:NPTH) acquired Healthpointe Medical Centres Ltd. for CAD 6.7 million.

New 90-day low: CA$0.72

New 90-day low: CA$0.75

NeuPath Health Inc. has completed a Composite Units Offering in the amount of CAD 10.44 million.

New 90-day high: CA$1.10

Insider recently bought CA$60k worth of stock

First half earnings released

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin